FR2450607A2 - Composition pharmaceutique contenant comme principe actif la flavopereine - Google Patents

Composition pharmaceutique contenant comme principe actif la flavopereine

Info

Publication number
FR2450607A2
FR2450607A2 FR7905853A FR7905853A FR2450607A2 FR 2450607 A2 FR2450607 A2 FR 2450607A2 FR 7905853 A FR7905853 A FR 7905853A FR 7905853 A FR7905853 A FR 7905853A FR 2450607 A2 FR2450607 A2 FR 2450607A2
Authority
FR
France
Prior art keywords
flavopereirine
antitumour
anticancer
compsn
antiviral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7905853A
Other languages
English (en)
Other versions
FR2450607B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7807155A external-priority patent/FR2419725A1/fr
Application filed by Individual filed Critical Individual
Priority to FR7905853A priority Critical patent/FR2450607A2/fr
Publication of FR2450607A2 publication Critical patent/FR2450607A2/fr
Application granted granted Critical
Publication of FR2450607B2 publication Critical patent/FR2450607B2/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION CONCERNE UNE NOUVELLE COMPOSITION PHARMACEUTIQUE CONTENANT COMME PRINCIPE ACTIF LA FLAVOPEREINE. ELLE POSSEDE UNE ACTION PREFERENTIELLE SUR LA REPLICATION DES ADN ET LA SYNTHESE DES ARN DES CELLULES TUMORALES, CANCEREUSES ET VIRALES.
FR7905853A 1978-03-13 1979-03-07 Composition pharmaceutique contenant comme principe actif la flavopereine Granted FR2450607A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7905853A FR2450607A2 (fr) 1978-03-13 1979-03-07 Composition pharmaceutique contenant comme principe actif la flavopereine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7807155A FR2419725A1 (fr) 1978-03-13 1978-03-13 Serpentine, alstonine et sempervirine, medicaments inhibant specifiquement les cellules cancereuses et tumorales
FR7905853A FR2450607A2 (fr) 1978-03-13 1979-03-07 Composition pharmaceutique contenant comme principe actif la flavopereine

Publications (2)

Publication Number Publication Date
FR2450607A2 true FR2450607A2 (fr) 1980-10-03
FR2450607B2 FR2450607B2 (fr) 1982-10-22

Family

ID=26220482

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7905853A Granted FR2450607A2 (fr) 1978-03-13 1979-03-07 Composition pharmaceutique contenant comme principe actif la flavopereine

Country Status (1)

Country Link
FR (1) FR2450607A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817A1 (fr) * 1981-03-11 1982-09-15 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
JPS57159712A (en) * 1981-03-24 1982-10-01 Beljanski Mirko Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug
FR2639830A1 (fr) * 1988-12-02 1990-06-08 Beljanski Mirko Composition antivirale et ses applications
WO1994002146A1 (fr) * 1992-07-28 1994-02-03 Abraxas Bio Labs Sa Composition pharmaceutique a base de flavopereirine et son utilisation dans un traitement contre le virus vih
WO2005112964A1 (fr) * 2004-05-19 2005-12-01 Natural Source International Combinaisons de flavopereirine et d'alstonine dans le traitement et la prevention du cancer de la prostate
US11083714B2 (en) 2018-03-31 2021-08-10 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CA1958 *
EXBK/58 *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817A1 (fr) * 1981-03-11 1982-09-15 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
JPS57159712A (en) * 1981-03-24 1982-10-01 Beljanski Mirko Serpentine, alstonine and sempervirine having controlling activity against cancer cell and tumor cell as drug
FR2639830A1 (fr) * 1988-12-02 1990-06-08 Beljanski Mirko Composition antivirale et ses applications
EP0373986A1 (fr) * 1988-12-02 1990-06-20 Abraxas Bio Labs S.A. Composition antivirale et ses applications
WO1994002146A1 (fr) * 1992-07-28 1994-02-03 Abraxas Bio Labs Sa Composition pharmaceutique a base de flavopereirine et son utilisation dans un traitement contre le virus vih
US5519028A (en) * 1992-07-28 1996-05-21 Beljanski; Mirko Antiviral preparations
WO2005112964A1 (fr) * 2004-05-19 2005-12-01 Natural Source International Combinaisons de flavopereirine et d'alstonine dans le traitement et la prevention du cancer de la prostate
US7341749B2 (en) * 2004-05-19 2008-03-11 Natural Source International Ltd. Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
US11083714B2 (en) 2018-03-31 2021-08-10 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Also Published As

Publication number Publication date
FR2450607B2 (fr) 1982-10-22

Similar Documents

Publication Publication Date Title
SE7602317L (sv) 1,4-dihydropyridinkarbonsyraalkylestrar till anvendning som lekemedel och sett att framstella desamma
ES8900006A1 (es) Un procedimiento para preparar un complejo de inmunogeno
DK0397060T3 (da) Maleinimidderivater og deres anvendelse som lægemidler
AU8199782A (en) Phosphoramidite derivatives of nucleotides and their use in preparation of oligonucleotides
LU90131I2 (fr) Interferon bêta - 1a et ses dérivés pharmaceutiquement acceptables (avonex)
IT1066689B (it) Procedimento per produrre pezzi stampati di carburo di silicio e pezzi cosi prodotti
GR3003503T3 (fr)
FR2450607A2 (fr) Composition pharmaceutique contenant comme principe actif la flavopereine
DE3873581D1 (de) Nitroglycerinarzneimittelpraeparat fuer perkutane absorption.
CA2145585A1 (fr) N-oxydes et derives du chlorambucil utiles pour le traitement des cellules de tumeurs hypoxiques
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
ATA395977A (de) Digitale bremssteuereinrichtung zur vermeidung des blockierens der fahrzeugraeder eines kraftfahrzeuges
DK188286A (da) Phenylalkyl-2,3-dihydrobenzofuraner og analoge heraf samt praeparater indeholdende disse forbindelser
CA2032254A1 (fr) Derives de glycerol, mode de preparation et compositions therapeutiques en contenant
OA06083A (fr) Nouvelles pipérazines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
HUP0302971A2 (hu) (2-Azabiciklo[2.2.1]hept-7-il)-metanol-származékok, eljárás az előállításukra és nikotinos acetilkolin-receptorok agonistájakénti alkalmazásuk
ATE1150T1 (de) Anthracyclinglycosiden, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen.
JPS52151114A (en) Preparation of dimethylforamide
ES2083489T3 (es) Derivados antracenicos de uso terapeutico y compuestos farmaceuticos que los contienen.
DK0466586T3 (da) Disubstituerede polymethyleniminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
GB2000029A (en) Anthraquinones for Cancer Therapy
SU645220A1 (ru) Держатель электронных ламп
JPS5251373A (en) Preparaton of pyrmidine ucleosides
FR2416228A1 (fr) Sulfures de 4-pyrimidyle, leur procede de preparation et leur application en therapeutique
Fouron Synthesis and reactions of 2', 3'-anhydronucleosides (nucleoside ribo and lyxo epoxides)

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
TP Transmission of property
SN Distraint notified (in the national patent register)
JU Final juridical decision affecting the ownership or exploitation of an industrial property right
ML Cancellation of distraint
TP Transmission of property